Finkelstein Thompson LLP Announces Investigation of Trius Therapeutics, Inc. Buyout
WOW.....don't you think Stein must be wondering if he showed his hand too early? Clearly, the lawyers and the market feel that we got the shaft in this deal. The stock is not even trading with a CVR factored in....what a fricken joke. Vote NO!!!
Yes, and more to follow. Everyone but Stein and Cubist knows this deal reaks for TSRX shareholders, and I'm not so sure they don't even know it. It's time they wake up, and up the ante......and I believe other suitors have waken up to the fact they could lose Tedizolid if they don't raise the stakes, and soon. I fully believe we'll get more from either Cubist, or from a large pharma.